BD Life Sciences President Dave Hickey to retire effective July 1, 2024

BECTON DICKINSON & CO

Dave Hickey, EVP and President of Life Sciences segment, announced retirement effective July 1, 2024.
Hickey held the role since January 2021; previously president of Integrated Diagnostic Solutions and Diagnostic Systems.
BD intends to name a successor prior to his retirement date.
Hickey joined BD in 2014 and led development of rapid and molecular COVID-19 diagnostic tests.
No financial or guidance changes disclosed in connection with the retirement.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Hickey

Executive Vice President and President of the Life Sciences segment

BDX · BECTON DICKINSON & CO

Effective: 2024-07-01
Filed: February 27, 2024, 6:59 PM ET

On February 22, 2024, David Hickey, Executive Vice President and President of the Life Sciences segment of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire, effective July 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Hickey departed as Executive Vice President and President of the Life Sciences segment at BECTON DICKINSON & CO.

Action: retire
Role: Executive Vice President and President of the Life Sciences segment

Exact text from the filing

On February 22, 2024, David Hickey, Executive Vice President and President of the Life Sciences segment of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire, effective July 1, 2024.

View on SEC.gov

BECTON DICKINSON & CO filing history →

Source: SEC EDGAR

accession 0000010795-24-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.